ClinicalTrials.gov
public full text
Public Domain
Cocaine Use Reduction and Health
Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced cocaine use. These data will be used to change current accepted cocaine treatment endpoints and accelerate identification of therapies for cocaine use disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Carbamazepine Treatment for Cocaine Dependence - 5#897329
- Inconsistent evidence on lay worker-delivered psychosocial interventions for people who use illicit drugs outside healthcare settings: a systematic review#355553
- Non-Abstinence Outcomes in Methamphetamine Use Disorder#994019
- Cannabidiol as a treatment for cocaine use disorder: a scoping review.#165561
- Mazindol for Cocaine Abuse - 2#1125241
Record · ID 1010290
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive